Search This Blog

Tuesday, February 5, 2019

Teva announces launch of ALYQ in U.S.

Teva announced the launch of ALYQ, a generic version of ADCIRCA tablets, 20 mg in the U.S. ADCIRCA had annual total sales of approximately $490M in the U.S., according to IQVIA data as of November 2018.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)